Global Next-Generation Biologics Market 2016-2020
- SKU ID : TNV-IRTNTR10904 10388211
- |
- Publishing Date: 25-Nov-2016
- |
- Region: Global
- |
- No. of pages: 124
About Next-generation Biologics
According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a “virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings.” Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine or derivative of arsphenamine intended for the treatment, prevention, or cure of a disease or condition. The differences between the small molecules and biologics includes the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics usually have a higher molecular weight and a complex molecular structure. They are usually derived from living organisms, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures and light.
Technavio’s analysts forecast the global next-generation biologics market to grow at a CAGR of 14.42% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global next-generation biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of next-generation biologics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Next-generation Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hofmann-La Roche
• Novo Nordisk
• Sanofi
• Takeda Pharmaceuticals
Other prominent vendors
• Aastrom Biosciences
• AbbVie
• AbGenomics
• Acologix
• ADC Therapeutics
• Adocia
• Agensys
• AlloCure
• AlloSource
• ALMAC Group
• Alphatec Spine
• Ambrx
• Amorcyte
• Argos Therapeutics
• Astellas Pharma
• AstraZeneca
• Athersys
• Avita Medical
• Baxter
• Bayer HealthCare
• Bellicum Pharmaceuticals
• BioCardia
• Biocon
• Biodel
• BIOGENOMICS
• BioLife Solutions
• BioRestorative Therapies
• BioTissue Technologies
• Bluebird Bio
• Boehringer Ingelheim
• BrainStorm Cell Therapeutics
• Calimmune
• Capricor
• CARBOGEN AMCIS
• Cell Medica
• Celldex Therapeutics
• Celyad (Cardio3 BioSciences)
• Cesca
• CryoLife
• CSL Behring
• Cynata Therapeutics
• Daiichi Sankyo
• Dance Biopharm
• Dendreon
• Diasome Pharmaceuticals
• DiscGenics
• Endo Pharmaceuticals
• Esperance Pharmaceuticals
• Exsulin
• Fate Therapeutics
• Fibrocell Science
• Formation Biologics
• Forticell Bioscience
• Fortress Biotech
• Gamida Cell
• GENEREX
• Genmab
• Geron
• GlaxoSmithKline
• Harvard Apparatus Regenerative Technology
• Healthpoint
• Histogen
• Histogenics
• Humacyte
• Immunocellular Therapeutics
• Immunogen
• Integra LifeSciences
• InVivo Therapeutics
• ISTO Technologies
• Juno Therapeutics
• Juventas Therapeutics
• Kairos Therapeutics
• Kensey Nash
• Kiadis Pharma
• Kinetic Concept
• Living Cell Technologies
• MacroGenics
• MannKind
• MaxCyte
• MedImmune
• Medtronic
• Mersana Therapeutics
• Mesoblast
• MiMedx
• Nanofiber Solutions
• Nanotope
• Neuralstem
• NewLink Genetics
• NGM Biopharmaceuticals
• Northwest Biotherapeutics
• Novartis
• NovaRx
• Ocata Therapeutics
• Opexa Therapeutics
• Oramed Pharmaceuticals
• Organovo
• Orteq
• Orthofix
• Osiris Therapeutics
• Osteotech
• OXFORD BioTherapeutics
• Pfizer
• PhaseBio Pharmaceuticals
• Pluristem Therapeutics
• Prima BioMed
• Q Therapeutics
• ReproCELL
• RhinoCyte
• RTI Surgical
• SanBio
• Sangamo
• Shire Regenerative Medicine
• STEMCELL Technologies
• Stemcentrx
• Stratatech
• Synthon Biopharmaceuticals
• TEI Biosciences
• Tengion
• Thermalin Diabetes
• TiGenix
• Tissue Genesis
• TissueGene
• Tolerion
• VentriNova
• Vericel
• VeroScience
• ViaCyte
• VistaGen Therapeutics
• vTv Therapeutics
• Wockhardt
• XOMA
• Zimmer Biomet
• Zymeworks
Market driver
• Advanced technological innovations
• For a full, detailed list, view our report
Market challenge
• Complexities in manufacturing of biologics
• For a full, detailed list, view our report
Market trend
• Development of gene and cell therapy-based products
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a “virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings.” Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine or derivative of arsphenamine intended for the treatment, prevention, or cure of a disease or condition. The differences between the small molecules and biologics includes the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics usually have a higher molecular weight and a complex molecular structure. They are usually derived from living organisms, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures and light.
Technavio’s analysts forecast the global next-generation biologics market to grow at a CAGR of 14.42% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global next-generation biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of next-generation biologics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market during the forecast period.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Next-generation Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• F. Hofmann-La Roche
• Novo Nordisk
• Sanofi
• Takeda Pharmaceuticals
Other prominent vendors
• Aastrom Biosciences
• AbbVie
• AbGenomics
• Acologix
• ADC Therapeutics
• Adocia
• Agensys
• AlloCure
• AlloSource
• ALMAC Group
• Alphatec Spine
• Ambrx
• Amorcyte
• Argos Therapeutics
• Astellas Pharma
• AstraZeneca
• Athersys
• Avita Medical
• Baxter
• Bayer HealthCare
• Bellicum Pharmaceuticals
• BioCardia
• Biocon
• Biodel
• BIOGENOMICS
• BioLife Solutions
• BioRestorative Therapies
• BioTissue Technologies
• Bluebird Bio
• Boehringer Ingelheim
• BrainStorm Cell Therapeutics
• Calimmune
• Capricor
• CARBOGEN AMCIS
• Cell Medica
• Celldex Therapeutics
• Celyad (Cardio3 BioSciences)
• Cesca
• CryoLife
• CSL Behring
• Cynata Therapeutics
• Daiichi Sankyo
• Dance Biopharm
• Dendreon
• Diasome Pharmaceuticals
• DiscGenics
• Endo Pharmaceuticals
• Esperance Pharmaceuticals
• Exsulin
• Fate Therapeutics
• Fibrocell Science
• Formation Biologics
• Forticell Bioscience
• Fortress Biotech
• Gamida Cell
• GENEREX
• Genmab
• Geron
• GlaxoSmithKline
• Harvard Apparatus Regenerative Technology
• Healthpoint
• Histogen
• Histogenics
• Humacyte
• Immunocellular Therapeutics
• Immunogen
• Integra LifeSciences
• InVivo Therapeutics
• ISTO Technologies
• Juno Therapeutics
• Juventas Therapeutics
• Kairos Therapeutics
• Kensey Nash
• Kiadis Pharma
• Kinetic Concept
• Living Cell Technologies
• MacroGenics
• MannKind
• MaxCyte
• MedImmune
• Medtronic
• Mersana Therapeutics
• Mesoblast
• MiMedx
• Nanofiber Solutions
• Nanotope
• Neuralstem
• NewLink Genetics
• NGM Biopharmaceuticals
• Northwest Biotherapeutics
• Novartis
• NovaRx
• Ocata Therapeutics
• Opexa Therapeutics
• Oramed Pharmaceuticals
• Organovo
• Orteq
• Orthofix
• Osiris Therapeutics
• Osteotech
• OXFORD BioTherapeutics
• Pfizer
• PhaseBio Pharmaceuticals
• Pluristem Therapeutics
• Prima BioMed
• Q Therapeutics
• ReproCELL
• RhinoCyte
• RTI Surgical
• SanBio
• Sangamo
• Shire Regenerative Medicine
• STEMCELL Technologies
• Stemcentrx
• Stratatech
• Synthon Biopharmaceuticals
• TEI Biosciences
• Tengion
• Thermalin Diabetes
• TiGenix
• Tissue Genesis
• TissueGene
• Tolerion
• VentriNova
• Vericel
• VeroScience
• ViaCyte
• VistaGen Therapeutics
• vTv Therapeutics
• Wockhardt
• XOMA
• Zimmer Biomet
• Zymeworks
Market driver
• Advanced technological innovations
• For a full, detailed list, view our report
Market challenge
• Complexities in manufacturing of biologics
• For a full, detailed list, view our report
Market trend
• Development of gene and cell therapy-based products
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
